Clovis Oncology Inc Net debt/EBITDA
What is the Net debt/EBITDA of Clovis Oncology Inc?
The Net debt/EBITDA of Clovis Oncology Inc is -11.04
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on NASDAQ compared to Clovis Oncology Inc
Companies with net debt/ebitda similar to Clovis Oncology Inc
- M&G Plc has Net debt/EBITDA of -11.08
- China Yurun Food has Net debt/EBITDA of -11.06
- Veritex Inc has Net debt/EBITDA of -11.06
- Fox Marble PLC has Net debt/EBITDA of -11.05
- Trisura has Net debt/EBITDA of -11.05
- Avantium NV has Net debt/EBITDA of -11.04
- Clovis Oncology Inc has Net debt/EBITDA of -11.04
- Wayside Technology Inc has Net debt/EBITDA of -11.00
- Alico has Net debt/EBITDA of -11.00
- Maxicity has Net debt/EBITDA of -10.99
- Huadian Fuxin has Net debt/EBITDA of -10.99
- Opiant Pharmaceuticals Inc has Net debt/EBITDA of -10.98
- Sigma Lithium has Net debt/EBITDA of -10.98